Application Sponsors
| ANDA 040870 | SUN PHARM INDS INC | |
Marketing Status
| Discontinued | 001 |
| Discontinued | 002 |
Application Products
| 001 | TABLET;ORAL | 5MG | 0 | METHIMAZOLE | METHIMAZOLE |
| 002 | TABLET;ORAL | 10MG | 0 | METHIMAZOLE | METHIMAZOLE |
FDA Submissions
| ORIG | 1 | AP | 2007-09-25 | |
| LABELING; Labeling | SUPPL | 7 | AP | 2016-01-15 | STANDARD |
| LABELING; Labeling | SUPPL | 8 | AP | 2019-01-18 | STANDARD |
Submissions Property Types
| ORIG | 1 | Null | 1 |
| SUPPL | 7 | Null | 7 |
| SUPPL | 8 | Null | 7 |
CDER Filings
SUN PHARM INDS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 40870
[companyName] => SUN PHARM INDS INC
[docInserts] => ["",""]
[products] => [{"drugName":"METHIMAZOLE","activeIngredients":"METHIMAZOLE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"METHIMAZOLE","activeIngredients":"METHIMAZOLE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"METHIMAZOLE","submission":"METHIMAZOLE","actionType":"5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"METHIMAZOLE","submission":"METHIMAZOLE","actionType":"10MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)